Back
Mersana Therapeutics Stock Predictions

Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
28
MRSN
Mersana Therapeutics
Last Price:
$0.31
Seasonality Move:
-7.32%
7 Day Trial
ALL ACCESS PASS
$
7

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Mersana Therapeutics Stock Forecast
-
Is Mersana Therapeutics Stock Undervalued?The current Mersana Therapeutics [MRSN] share price is $0.32. The Score for MRSN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
MRSN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Mersana Therapeutics Stock Go Up Next Year?
Data Unavailable
Mersana Therapeutics Stock Rating
Data Unavailable
Mersana Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
mersana.com
52-Week Data
52-Week High:
2.88
52-Week Low:
0.26
Prediction Charts
Market Cap:
39.7M
Price in USD:
0.32
Volume:
2M
Beta:
1.66
Technical Analysis
SMA50:
0.40
SMA100:
0.71
SMA200:
1.31
52-Wk Change:
-87.06%
Stock Predictions
-
Is Mersana Therapeutics stock public?Yes, Mersana Therapeutics is a publicly traded company.
-
What is the Mersana Therapeutics stock quote today?The Mersana Therapeutics stock price is 0.32 USD today.
-
How to buy Mersana Therapeutics stock online?You can buy Mersana Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-22 | 0.33 | 0.38 | 0.38 | 0.33 |
Apr-23 | 0.39 | 0.39 | 0.43 | 0.37 |
Apr-24 | 0.39 | 0.36 | 0.39 | 0.36 |
Apr-25 | 0.37 | 0.36 | 0.37 | 0.35 |
Apr-28 | 0.36 | 0.38 | 0.39 | 0.36 |
Apr-29 | 0.36 | 0.37 | 0.39 | 0.34 |
Apr-30 | 0.36 | 0.43 | 0.44 | 0.35 |
May-1 | 0.43 | 0.40 | 0.43 | 0.38 |
May-2 | 0.41 | 0.40 | 0.41 | 0.38 |
May-5 | 0.39 | 0.37 | 0.39 | 0.36 |
May-6 | 0.36 | 0.32 | 0.36 | 0.31 |
May-7 | 0.33 | 0.32 | 0.34 | 0.31 |
May-8 | 0.32 | 0.34 | 0.34 | 0.32 |
May-9 | 0.33 | 0.32 | 0.35 | 0.31 |
Mersana Therapeutics Earnings
Data Unavailable
Mersana Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.16 per share, and an increase next year of $0.11 per share.
* Mersana Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.